Reciprocal expression of trefoil factor‐1 and thyroid transcription factor‐1 in lung adenocarcinomas

Molecular targeted therapies against EGFR and ALK have improved the quality of life of lung adenocarcinoma patients. However, targetable driver mutations are mainly found in thyroid transcription factor‐1 (TTF‐1)/NK2 homeobox 1 (NKX2‐1)‐positive terminal respiratory unit (TRU) types and rarely in no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Matsubara, Daisuke, Yoshimoto, Taichiro, Soda, Manabu, Amano, Yusuke, Kihara, Atsushi, Funaki, Toko, Ito, Takeshi, Sakuma, Yuji, Shibano, Tomoki, Endo, Shunsuke, Hagiwara, Koichi, Ishikawa, Shumpei, Fukayama, Masashi, Murakami, Yoshinori, Mano, Hiroyuki, Niki, Toshiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293082/
https://ncbi.nlm.nih.gov/pubmed/32237253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados